Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

REATA PHARMACEUTICALS INC (RETA) Class Action Lawsuit (October 2020)

Closed

4:20cv796 • October 15, 2020

Class Period Start

October 15, 2019

Class Period End

August 7, 2020

PSLRA Deadline

December 14, 2020

Case Allegations

10b5

Statutes of Repose

Oct 15, 2022

Country

United States

Court

Federal Court

Docket History

Sep 27, 2021

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Aug 10, 2021

Scheduling Order

Jul 15, 2021

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Oct 15, 2020

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in REATA PHARMACEUTICALS INC.

TOP